Skip to main content
. Author manuscript; available in PMC: 2014 Aug 12.
Published in final edited form as: Cancer Res. 2010 May 18;70(11):4624–4633. doi: 10.1158/0008-5472.CAN-09-3619

Table 1.

Summary of in vivo tumorigenicity of six pleural effusions and xenografts sorted into CD44posCD24neg/dim and CD44posCD24pos populations

Tumor Tumors/injection
250 500 1,000
SH5 xenograft
  CD44posCD24pos 2/4 2/2
  CD44posCD24neg/dim 3/4 4/4
  CD44neg 0/2 0/3
SH12 pleural effusion
  CD44posCD24pos 0/4 0/6
  CD44posCD24neg/dim 2/6 2/4
SH12 xenograft
  CD44posCD24pos 1/4 4/4
  CD44posCD24neg/dim 3/5 1/2
SH1 pleural effusion
  CD44posCD24pos 4/4
  CD44posCD24neg/dim 0/3
  CD44neg 0/5
SH1 xenograft
  CD44posCD24pos 1/5
  CD44neg 1/5
012 xenograft
  CD44posCD24pos 1/5
  CD44 pos CD24 neg/dim 1/5
  CD44neg 0/5